Tianjin Medical Journal ›› 2023, Vol. 51 ›› Issue (11): 1199-1204.doi: 10.11958/20221777
• Experimental Research • Previous Articles Next Articles
Received:
2022-11-07
Revised:
2023-03-13
Published:
2023-11-15
Online:
2023-11-07
Contact:
△E-mail:MAO Quanxi, LI Zuoxiao. Neuroprotective mechanism of edaravone dexborneol in rats with cerebral hemorrhage through ferroptosis-lipid peroxidation pathway[J]. Tianjin Medical Journal, 2023, 51(11): 1199-1204.
CLC Number:
组别 | n | 神经功能评分 | F | |||
---|---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | |||
假手术组 | 8 | 17.75±0.46 | 17.75±0.46 | 17.88±0.35 | 18.00±0.00 | 0.828 |
脑出血组 | 8 | 11.88±1.13a | 9.50±0.93aA | 13.38±0.92aAB | 14.75±0.89aABC | 43.110* |
依达拉奉组 | 8 | 13.25±1.28b | 11.63±1.06bA | 14.75±1.04bAB | 16.00±0.76bABC | 25.950* |
依达拉奉右莰醇组 | 8 | 14.25±0.89bc | 13.38±0.74bcA | 15.88±0.64bcAB | 17.50±0.53bcABC | 52.234* |
F | 55.514* | 142.848* | 47.331* | 42.507* |
Tab.1 Comparison of neurological function scores between the four groups of rats
组别 | n | 神经功能评分 | F | |||
---|---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | |||
假手术组 | 8 | 17.75±0.46 | 17.75±0.46 | 17.88±0.35 | 18.00±0.00 | 0.828 |
脑出血组 | 8 | 11.88±1.13a | 9.50±0.93aA | 13.38±0.92aAB | 14.75±0.89aABC | 43.110* |
依达拉奉组 | 8 | 13.25±1.28b | 11.63±1.06bA | 14.75±1.04bAB | 16.00±0.76bABC | 25.950* |
依达拉奉右莰醇组 | 8 | 14.25±0.89bc | 13.38±0.74bcA | 15.88±0.64bcAB | 17.50±0.53bcABC | 52.234* |
F | 55.514* | 142.848* | 47.331* | 42.507* |
组别 | ROS含量 | F | |||
---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 401.13±34.85 | 419.31±12.77 | 469.35±50.88 | 423.93±40.35 | 3.006 |
脑出血组 | 2 627.93±191.86a | 4 843.82±248.58aA | 4 259.69±252.67aAB | 2 301.21±162.10aABC | 161.608* |
依达拉奉组 | 2 575.42±232.30 | 4 208.64±151.22bA | 2 780.60±307.92bB | 1 353.92±130.66bBC | 145.064* |
依达拉奉右莰醇组 | 2 378.65±193.52b | 2 850.56±271.71bcA | 1 560.46±181.28bcAB | 648.05±29.06bcABC | 129.150* |
F | 176.405* | 438.943* | 273.577* | 311.623* |
Tab.2 Changes of ROS content in brain tissue around hematoma of rats in each group
组别 | ROS含量 | F | |||
---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 401.13±34.85 | 419.31±12.77 | 469.35±50.88 | 423.93±40.35 | 3.006 |
脑出血组 | 2 627.93±191.86a | 4 843.82±248.58aA | 4 259.69±252.67aAB | 2 301.21±162.10aABC | 161.608* |
依达拉奉组 | 2 575.42±232.30 | 4 208.64±151.22bA | 2 780.60±307.92bB | 1 353.92±130.66bBC | 145.064* |
依达拉奉右莰醇组 | 2 378.65±193.52b | 2 850.56±271.71bcA | 1 560.46±181.28bcAB | 648.05±29.06bcABC | 129.150* |
F | 176.405* | 438.943* | 273.577* | 311.623* |
组别 | GSH含量 | F | |||
---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 15.44±1.19 | 15.19±1.27 | 15.16±1.18 | 16.04±0.40 | 0.725 |
脑出血组 | 5.54±0.60a | 0.90±0.76aA | 2.14±0.86aAB | 7.28±1.18aABC | 56.782* |
依达拉奉组 | 6.54±1.10 | 1.27±0.98A | 6.11±0.95bB | 9.8±0.79bABC | 67.218* |
依达拉奉右莰醇组 | 6.92±0.71b | 2.95±1.04bcA | 7.55±0.94bcB | 14.89±1.34bcABC | 116.679* |
F | 121.032* | 219.383* | 152.153* | 86.897* |
Tab.3 Changes of GSH content in brain tissue around hematoma of rats in each group
组别 | GSH含量 | F | |||
---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 15.44±1.19 | 15.19±1.27 | 15.16±1.18 | 16.04±0.40 | 0.725 |
脑出血组 | 5.54±0.60a | 0.90±0.76aA | 2.14±0.86aAB | 7.28±1.18aABC | 56.782* |
依达拉奉组 | 6.54±1.10 | 1.27±0.98A | 6.11±0.95bB | 9.8±0.79bABC | 67.218* |
依达拉奉右莰醇组 | 6.92±0.71b | 2.95±1.04bcA | 7.55±0.94bcB | 14.89±1.34bcABC | 116.679* |
F | 121.032* | 219.383* | 152.153* | 86.897* |
组别 | ACSL4 | F | |||
---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 0.06±0.01 | 0.06±0.01 | 0.06±0.01 | 0.06±0.01 | 0.000 |
脑出血组 | 0.43±0.03a | 0.72±0.03aA | 0.59±0.02aAB | 0.28±0.04aABC | 209.196* |
依达拉奉组 | 0.38±0.04b | 0.65±0.04bA | 0.48±0.03bAB | 0.18±0.03bABC | 164.729* |
依达拉奉右莰醇组 | 0.30±0.03bc | 0.49±0.05bcA | 0.19±0.04bcAB | 0.09±0.01bcABC | 125.193* |
F | 162.535* | 383.899* | 451.068* | 76.947* | |
组别 | LPCAT3 | F | |||
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 0.08±0.01 | 0.08±0.01 | 0.08±0.01 | 0.08±0.01 | 0.000 |
脑出血组 | 0.59±0.03a | 0.84±0.03aA | 0.71±0.04aAB | 0.39±0.02aABC | 194.560* |
依达拉奉组 | 0.55±0.06 | 0.74±0.07bA | 0.57±0.03bB | 0.27±0.03bABC | 76.592* |
依达拉奉右莰醇组 | 0.41±0.03bc | 0.54±0.04bcA | 0.24±0.04bcAB | 0.12±0.04bcABC | 120.285* |
F | 191.531* | 338.113* | 366.208* | 128.922* | |
组别 | GPX4 | F | |||
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 0.70±0.03 | 0.70±0.03 | 0.70±0.03 | 0.70±0.03 | 0.000 |
脑出血组 | 0.41±0.04a | 0.15±0.04aA | 0.25±0.03aAB | 0.49±0.03aABC | 84.135* |
依达拉奉组 | 0.49±0.04b | 0.27±0.03bA | 0.32±0.03bAB | 0.58±0.02bABC | 111.808* |
依达拉奉右莰醇组 | 0.56±0.04bc | 0.35±0.03bcA | 0.49±0.06bcAB | 0.66±0.03bcABC | 50.498* |
F | 491.616* | 865.259* | 749.863* | 134.870* |
Tab.4 Changes of ACSL4, LPCAT3 and GPX4 expression in brain tissue around hematoma of rats in each group
组别 | ACSL4 | F | |||
---|---|---|---|---|---|
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 0.06±0.01 | 0.06±0.01 | 0.06±0.01 | 0.06±0.01 | 0.000 |
脑出血组 | 0.43±0.03a | 0.72±0.03aA | 0.59±0.02aAB | 0.28±0.04aABC | 209.196* |
依达拉奉组 | 0.38±0.04b | 0.65±0.04bA | 0.48±0.03bAB | 0.18±0.03bABC | 164.729* |
依达拉奉右莰醇组 | 0.30±0.03bc | 0.49±0.05bcA | 0.19±0.04bcAB | 0.09±0.01bcABC | 125.193* |
F | 162.535* | 383.899* | 451.068* | 76.947* | |
组别 | LPCAT3 | F | |||
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 0.08±0.01 | 0.08±0.01 | 0.08±0.01 | 0.08±0.01 | 0.000 |
脑出血组 | 0.59±0.03a | 0.84±0.03aA | 0.71±0.04aAB | 0.39±0.02aABC | 194.560* |
依达拉奉组 | 0.55±0.06 | 0.74±0.07bA | 0.57±0.03bB | 0.27±0.03bABC | 76.592* |
依达拉奉右莰醇组 | 0.41±0.03bc | 0.54±0.04bcA | 0.24±0.04bcAB | 0.12±0.04bcABC | 120.285* |
F | 191.531* | 338.113* | 366.208* | 128.922* | |
组别 | GPX4 | F | |||
1 d | 3 d | 7 d | 14 d | ||
假手术组 | 0.70±0.03 | 0.70±0.03 | 0.70±0.03 | 0.70±0.03 | 0.000 |
脑出血组 | 0.41±0.04a | 0.15±0.04aA | 0.25±0.03aAB | 0.49±0.03aABC | 84.135* |
依达拉奉组 | 0.49±0.04b | 0.27±0.03bA | 0.32±0.03bAB | 0.58±0.02bABC | 111.808* |
依达拉奉右莰醇组 | 0.56±0.04bc | 0.35±0.03bcA | 0.49±0.06bcAB | 0.66±0.03bcABC | 50.498* |
F | 491.616* | 865.259* | 749.863* | 134.870* |
[1] | KLEBE D, INIAGHE L, BURCHELL S, et al. Intracerebral hemorrhage in mice[J]. Methods Mol Biol, 2018, 1717:83-91. doi:10.1007/978-1-4939-7526-6_7. |
[2] | YAO M Y, LIU T, ZHANG L, et al. Role of ferroptosis in neurological diseases[J]. Neurosci Lett, 2021, 747:135614. doi:10.1016/j.neulet.2020.135614. |
[3] | MIYAKE S, SHINDO R, NAKANO H. The molecular mechanisms and the functions of new types of regulated cell death including necroptosis,ferroptosis,and pyroptosis[J]. Clin Calcium, 2019, 29(2):248-253. doi:10.20837/4201902248. |
[4] | XU J, WANG A, MENG X, et al. Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke:A phase Ⅲ,randomized,double-blind,comparative trial[J]. Stroke, 2021, 52(3):772-780. doi:10.1161/STROKEAHA.120.031197. |
[5] | 李秋畅, 闫顺昌, 蒙亚珍, 等. Nrf2-GPX4介导的铁死亡通路参与右美托咪定对脑出血大鼠神经保护作用的机制研究[J]. 天津医药, 2022, 50(8):817-821. |
LI Q C, YAN S C, MENG Y Z, et al. Neuroprotective effects of dexmedetomidine on intracerebral hemorrhage of rats by Nrf2-GPX4 mediated iron death pathway[J]. Tianjin Med J, 2022, 50(8):817-821. doi:10.11958/20212825. | |
[6] | GARCIA J H, WAGNER S, LIU K F, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation[J]. Stroke, 1995, 26(4):627-634; discussion635. doi:10.1161/01.str.26.4.627. |
[7] | AL-KAWAZ M N, HANLEY D F, ZIAI W. Advances in therapeutic approaches for spontaneous intracerebral hemorrhage[J]. Neurotherapeutics, 2020, 17(4):1757-1767. doi:10.1007/s13311-020-00902-w. |
[8] | ZILLE M, KARUPPAGOUNDER S S, CHEN Y X, et al. Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis[J]. Stroke, 2017, 48(4):1033-1043. doi:10.1161/STROKEAHA.116.015609. |
[9] | BAI Q, LIU J, WANG G. Ferroptosis,a regulated neuronal cell death type after intracerebral hemorrhage[J]. Front Cell Neurosci, 2020, 14:591874. doi:10.3389/fncel.2020.591874. |
[10] | BAO W D, ZHOU X T, ZHOU L T, et al. Targeting miR-124/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model[J]. Aging Cell, 2020, 19(11):e13235. doi:10.1111/acel.13235. |
[11] | AGMON E, SOLON J, BASSEREAU P, et al. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties[J]. Sci Rep, 2018, 8(1):5155. doi:10.1038/s41598-018-23408-0. |
[12] | BOURGEOIS T, JALIL A, THOMAS C, et al. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet[J]. J Lipid Res, 2021, 62:100013. doi:10.1194/jlr.RA120000737. |
[13] | KUWATA H, NAKATANI E, SHIMBARA-MATSUBAYASHI S, et al. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2019, 1864(11):1606-1618. doi:10.1016/j.bbalip.2019.07.013. |
[14] | REICHERT C O, DE FREITAS F A, SAMPAIO-SILVA J, et al. Ferroptosis mechanisms involved in neurodegenerative diseases[J]. Int J Mol Sci, 2020, 21(22):8765. doi:10.3390/ijms21228765. |
[15] | URSINI F, MAIORINO M. Lipid peroxidation and ferroptosis:the role of GSH and GPx4[J]. Free Radic Biol Med, 2020, 152:175-185. doi:10.1016/j.freeradbiomed.2020.02.027. |
[16] | STOCKWELL B R, JIANG X J, GU W. Emerging mechanisms and disease relevance of ferroptosis[J]. Trends Cell Biol, 2020, 30(6):478-490. doi:10.1016/j.tcb.2020.02.009. |
[17] | SU L J, ZHANG J H, GOMEZ H, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis,autophagy,and ferroptosis[J]. Oxid Med Cell Longev, 2019, 2019:5080843. doi:10.1155/2019/5080843. |
[18] | FUJIWARA N, SOM A T, PHAM L D D, et al. A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model[J]. Neurosci Lett, 2016, 633:7-13. doi:10.1016/j.neulet.2016.08.048. |
[19] | ZHANG M, TENG C H, WU F F, et al. Edaravone attenuates traumatic brain injury through anti-inflammatory and anti-oxidative modulation[J]. Exp Ther Med, 2019, 18(1):467-474. doi:10.3892/etm.2019.7632. |
[20] | DANG L, DONG X, YANG J. Influence of nanoparticle-loaded edaravone on postoperative effects in patients with cerebral hemorrhage[J]. J Nanosci Nanotechnol, 2021, 21(2):1202-1211. doi:10.1166/jnn.2021.18668. |
[21] | ZHANG J B, SHI X, CHEN Z, et al. Edaravone reduces iron-mediated Hydrocephalus and behavioral disorder in rat by activating the Nrf2/HO-1 pathway[J]. J Stroke Cerebrovasc Dis, 2018, 27(12):3511-3520. doi:10.1016/j.jstrokecerebrovasdis.2018.08.019. |
[22] | HOMMA T, KOBAYASHI S, SATO H, et al. Edaravone,a free radical scavenger,protects against ferroptotic cell death in vitro[J]. Exp Cell Res, 2019, 384(1):111592. doi:10.1016/j.yexcr.2019.111592. |
[23] | LIU R, ZHANG L, LAN X, et al. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion:involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway[J]. Neuroscience, 2011, 176:408-419. doi:10.1016/j.neuroscience.2010.11.029. |
[24] | WU H Y, TANG Y, GAO L Y, et al. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke[J]. Eur J Pharmacol, 2014, 740:522-531. doi:10.1016/j.ejphar.2014.06.035. |
[25] | HUA Y, ZHOU L M, YANG W D, et al. Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats[J]. Eur J Pharmacol, 2021, 910:174507. doi:10.1016/j.ejphar.2021.174507. |
[1] | ZHANG Chunhong, HUANG Hongchao, LIU Yue, DU Lilong, XU Haiwei, LI Ning, LI Yongjin. Identification of key ferroptosis genes in paraspinal muscle degeneration based on RNA sequencing and bioinformatics analysis [J]. Tianjin Medical Journal, 2024, 52(9): 991-995. |
[2] | LIU Bin, YANG Long, LI Wenli, SHAO Ningning, DONG Jinrui. Mechanism of microglia ferroptosis in smoke inhalation-induced brain injury [J]. Tianjin Medical Journal, 2024, 52(8): 791-797. |
[3] | WANG Xinshuang, AN Yajuan, GUAN Xiuju, LI Jiao, LIU Yue, WEI Liping, QI Xin. Study of magnesium isoglycyrrhizinate in ameliorating cisplatin induced myocardial injury in rats [J]. Tianjin Medical Journal, 2024, 52(8): 809-814. |
[4] | WU Xiaoxiao, HU Yukun, WU Jiang. Protective effect of asiatic acid on brain injury after experimental subarachnoidhemorrhage in rats [J]. Tianjin Medical Journal, 2024, 52(3): 285-289. |
[5] | ZHANG Wenchao, YANG Xuehui, YIN Tao, WANG Ruijian, ZHANG Mengmeng. The relationship between plasma sCD163/sTWEAK ratio and prognosis in patients with spontaneous acute cerebral hemorrhage [J]. Tianjin Medical Journal, 2024, 52(3): 297-301. |
[6] | HUANG Xiaolei, GE Tingting, ZHAO Junsong, NI Zhihua. Study on the role of ginsenoside Rg1 in IL-6-induced neuronal ferroptosis in rats [J]. Tianjin Medical Journal, 2024, 52(11): 1137-1140. |
[7] | NIE Yameng, ZHANG Xiaoqiang, FENG Pengzhan, DING Yaqian. Effects of edaravone dexborneol combined with rt-PA intravenous thrombolysis therapy on efficacy and prognosis of ultra-early acute cerebral infarction [J]. Tianjin Medical Journal, 2023, 51(7): 766-770. |
[8] | LI Yanping, WANG Xietao, SHI Libin, LIU Qiong. Influence of resveratrol on H2O2-induced ferroptosis in alveolar epithelial cells by regulating the Nrf2-GPX4 pathway [J]. Tianjin Medical Journal, 2023, 51(6): 568-572. |
[9] | ZHANG Xiufeng, LI Xiaofei, LIU Ming, WANG Huijing. Eucommia ulmoides leaves total flavonoids participate in the repair of neural function in rats with cerebral hemorrhage through RhoA/ROCK signaling pathway [J]. Tianjin Medical Journal, 2023, 51(3): 252-258. |
[10] | HU Yingshan, WANG Jingjing, GAO Hongmei. Research progress in the pathogenesis of sepsis-related intestinal dysfunction [J]. Tianjin Medical Journal, 2023, 51(3): 333-336. |
[11] | WANG Ke, YE Hanlu. Effect and its mechanism of emodin on the ferroptosis of chondrocytes in rats with knee osteoarthritis [J]. Tianjin Medical Journal, 2023, 51(10): 1090-1097. |
[12] | XIONG Xicheng, WANG Yiping, WANG Gang, ZHANG Tian, BAO Yali, Di na·AINIWAER, SUN Zhan. Ferrostatin-1 delay D-gal induced cardiomyocyte senescence by inhibiting ferroptosis [J]. Tianjin Medical Journal, 2023, 51(1): 19-23. |
[13] | LI Qiuchang, YAN Shunchang, MENG Yazhen, GU Yunxia, NING Qiaoming, LI Na, WANG Zhihua. Neuroprotective effects of dexmedetomidine on intracerebral hemorrhage of rats by Nrf2-GPX4 mediated iron death pathway [J]. Tianjin Medical Journal, 2022, 50(8): 817-821. |
[14] | ZHANG Jing, SUN Hui, ZHU Lijun, FENG Ziren, DU Lin, MENG Aiguo△. Relationship between miR-27a expression and ferroptosis in the early stage of ischemic stroke of rats [J]. Tianjin Medical Journal, 2022, 50(6): 595-600. |
[15] | WAN Li, LI Zuoxiao△. Edaravone dexborneol reduces inflammation in mice with experimental autoimmune encephalomyelitis by inhibiting TLR4/NF-κB signaling pathway [J]. Tianjin Medical Journal, 2022, 50(5): 471-475. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||